Decadron /00016001/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 40.7%
Plasma Cell Myeloma 10.8%
Multiple Myeloma 8.2%
Pain 6.7%
Hypertension 5.2%
Constipation 4.5%
Pyrexia 3.0%
Renal Cell Carcinoma 3.0%
Adenocarcinoma Pancreas 2.2%
Gastritis 1.9%
Abdominal Distension 1.5%
Decreased Appetite 1.5%
Diarrhoea 1.5%
Fluid Replacement 1.5%
Intervertebral Disc Protrusion 1.5%
Metastatic Renal Cell Carcinoma 1.5%
Palmar-plantar Erythrodysaesthesia Syndrome 1.5%
Prophylaxis 1.5%
Viral Hepatitis Carrier 1.1%
Lung Adenocarcinoma 0.7%
Vomiting 20.0%
Diverticulitis 13.3%
Pyrexia 10.0%
Skin Disorder 10.0%
Thrombocytopenia 6.7%
Chest Pain 3.3%
Cholecystitis Chronic 3.3%
Interstitial Lung Disease 3.3%
Pain In Jaw 3.3%
Peroneal Nerve Palsy 3.3%
Pneumonia 3.3%
Poor Quality Drug Administered 3.3%
Sepsis Syndrome 3.3%
Staphylococcus Test Positive 3.3%
Syncope 3.3%
Weight Decreased 3.3%
Wound 3.3%
Concomitant
Product Used For Unknown Indication 50.8%
Prophylaxis 9.2%
Pain 5.0%
Breast Cancer 3.9%
Rheumatoid Arthritis 3.9%
Cancer Pain 2.4%
Nausea 2.4%
Dermatitis Acneiform 2.2%
Hypertension 2.2%
Prophylaxis Of Nausea And Vomiting 2.2%
Plasma Cell Myeloma 2.1%
Colon Cancer 1.9%
Constipation 1.9%
Premedication 1.8%
Diabetes Mellitus 1.5%
Lung Neoplasm Malignant 1.5%
Rectal Cancer Recurrent 1.5%
Non-small Cell Lung Cancer 1.3%
Ascites 1.2%
Insomnia 1.2%
Vomiting 13.1%
Malignant Neoplasm Progression 8.2%
Death 6.6%
Off Label Use 6.6%
Pleural Effusion 6.6%
Renal Failure 6.6%
Interstitial Lung Disease 4.9%
Pain 4.9%
Pneumonia 4.9%
Shock 4.9%
Lung Neoplasm Malignant 3.3%
Osteonecrosis Of Jaw 3.3%
Premature Baby 3.3%
Psoriatic Arthropathy 3.3%
Pyrexia 3.3%
Rash 3.3%
Renal Impairment 3.3%
Somnolence 3.3%
Speech Disorder 3.3%
Supraventricular Tachycardia 3.3%

Drug Data